Midatech Pharma Plc | CIK:0001643918 | 3

  • Filed: 4/24/2018
  • Entity registrant name: Midatech Pharma Plc (CIK: 0001643918)
  • Generator: Novaworks Software
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1643918/000121465918002960/0001214659-18-002960-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1643918/000121465918002960/mtph-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001643918
  • Open this page in separate window: Click
  • ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory

    25 Reserves

     

    The following describes the nature and purpose of each reserve within equity:

     

    Reserve Description and purpose
       
    Share premium Amount subscribed for share capital in excess of nominal value.
       
    Merger reserve Represents the difference between the fair value and nominal value of shares issued on the acquisition of subsidiary companies where the Company has elected to take advantage of merger relief.
       
    Shares to be issued Shares for which consideration has been received but which are not yet issued and which form part of consideration in a business combination.
       
    Foreign exchange reserve Gains/losses arising on retranslating the net assets of overseas operations into sterling.
       
    Accumulated deficit All other net gains and losses and transactions with owners (e.g. dividends) not recognised elsewhere.